Innovative Wearable Ultrasound Patch Enhances Monitoring for High-Risk Pregnancies

Researchers at the University of California, San Diego, have developed a novel wearable ultrasound patch designed to facilitate continuous fetal monitoring during pregnancy. This soft, flexible patch remains functional even with fetal and umbilical cord movements, providing extended real-time observation of fetal health.

The development of this technology, detailed in the journal Nature Biotechnology, represents a significant advancement for prenatal care. During clinical trials, the patch successfully detected prolonged abnormal fetal signals, prompting timely medical intervention through an early cesarean delivery. This capability underscores its potential in saving lives by enabling earlier detection of complications in high-risk pregnancies.

The utility of such a device is particularly promising for low-resource settings where access to skilled ultrasound technicians is limited. Traditionally, prenatal ultrasounds are limited to brief snapshots that require expertise in operation. In contrast, this new patch offers a hands-free solution, continuously tracking fetal anatomy and blood flow.

"This technology provides the potential for continuous prenatal monitoring in unprecedented ways," stated Geonho Park, a chemical and nanoengineering PhD student at UC San Diego, and co-first author of the study alongside Yizhou Bian, Hao Huang, and Sai Zhou. Park and his colleagues highlight the importance of the patch's sensing depth and autonomy in detecting complications over extended periods.

The engineering team employed autonomous tracking algorithms to maintain accurate measurements despite the constant movement of the fetus and umbilical cord. The device's ability to track dynamic blood flow changes, often missed by conventional ultrasounds, signifies a breakthrough for comprehensive maternal and fetal monitoring.

The research team, led by Professor Sheng Xu at the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, UC San Diego, aims to integrate the patch with wireless electronics for future compact use. Clinical evaluations conducted at Jacobs Medical Center (UC San Diego Health) and the John Radcliffe Hospital (University of Oxford) demonstrated the patch's efficacy in both healthy pregnancies and those complicated by conditions like gestational diabetes and pre-eclampsia.

This project received support from Wellcome Leap, the National Institutes of Health, and UC San Diego's Accelerating Innovation to Market program. Notably, some collaborators have roles in associated medical technology companies, though other authors have declared no conflicts of interest.

Further research and development continue as the team seeks to enhance the functionality and application of this promising technology, potentially transforming the landscape of maternal-fetal health monitoring.